Explore the latest in pneumonia, including advances in understanding the microbiology and optimal treatment of community-acquired and nosocomial infection.
This randomized clinical trial compares the effects of high-dose, standard-dose, and therapeutic anticoagulation on mortality and/or disease duration among patients with hypoxemic COVID-19 pneumonia in 23 hospitals in France.
This cohort study compares outcomes between mechanically ventilated patients with pneumonia due to COVID-19 and other etiologies.
This cohort study examines the association of 13-valent pneumococcal conjugate vaccine use with pneumonia, non–health care–associated pneumonia, and lobar pneumonia (LP) hospitalization among US Medicare beneficiaries 65 years or older.
This systematic review and meta-analysis investigates whether a shorter course of antibiotics is noninferior to a longer course for the treatment of nonsevere community-acquired pneumonia in children aged 2 to 59 months.
This cohort study examines whether perioperative gabapentin use among older adults after major surgery is associated with in-hospital adverse clinical events.
This cohort study investigates whether COVID-19 vaccination is associated with lower risk of intensive care unit (ICU) admission for COVID-19 pneumonia and compares baseline characteristics and outcomes of vaccinated vs unvaccinated patients admitted to an ICU.
This secondary analysis assesses the association of finerenone with pneumonia and COVID-19 adverse events in patients from 2 randomized clinical trials with type 2 diabetes and chronic kidney disease.
This cohort study of children with sickle cell disease (SCD) in a French hospital system examines the association of 13-valent pneumococcal conjugate vaccine implementation with incidence of acute chest syndrome (ACS).
This serial cross-sectional study used data from the Medicare Patient Safety Monitoring System for 2010 to 2019 to determine the change in the rate of adverse events in hospitalized patients.
This systematic review and meta-analysis examines the global patterns, including temporal trends, regional variations, and variant types, in the proportion of macrolide-resistant Mycoplasma pneumoniae infections.
This cross-sectional study evaluates whether patients with pneumonia admitted to hospitals with higher risk-standardized readmission rates had a higher risk of adverse events.
This cohort study investigates the thromboembolic risks associated with atrial fibrillation (AF) in patients with pneumonia, assesses the risk of recurrent AF, and examines the association of initiation of anticoagulation therapy with new-onset AF.
This cross-sectional study examines the association between private equity acquisition of short-term acute care hospitals and access to care, patient outcomes, and spending among Medicare beneficiaries hospitalized with acute medical conditions.
This cohort study of French patients with community-acquired pneumonia examines the prevalence of avoidable hospital readmission through a statistical analysis of manual physician case review.
This randomized clinical trial compares the clinical response to Gram stain–guided vs guideline-based antibiotic therapy in patients with ventilator-associated pneumonia.
Customize your JAMA Network experience by selecting one or more topics from the list below.